Acknowledgement
이 논문은 2021년도 정부 (보건복지부)의 재원으로 한국보건산업진흥원의 지원을 받아 수행된 연구임 (No. HF21C0092).
References
- Reginster JY, Burlet N. Osteoporosis: A still increasing prevalence. Bone. 2006 ; 38(2) : 4-9. doi: 10.1016/j.bone.2005.11.024.
- Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006 ; 17(12) : 1726-33. doi: 10.1007/s00198-006-0172-4. Epub 2006 Sep 16.
- Kemmak AR, Rezapour A, Jahangiri R, Nikjoo S, Farabi H, Soleimanpour S. Economic burden of osteoporosis in the world: A systematic review. Medical journal of the Islamic Republic of Iran. 2020 ; 34 : 154. doi: 10.34171/mjiri.34.154.
- Wawrzyniak A, Balawender K. Structural and Metabolic Changes in Bone. Animals. 2022 ; 12(15) : 1946. doi: 10.3390/ani12151946.
- Chen X, Wang Z, Duan N, Zhu G, Schwarz EM, Xie C. Osteoblast-Osteoclast Interactions. Connective tissue research. 2018 ; 59(2) : 99-107. doi: 10.1080/03008207.2017.1290085.
- Ji MX, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis Transl Med. 2015 ; 1(1) : 9-13. doi: 10.1016/j.cdtm.2015.02.006.
- Kennel KA, Drake MT. Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management. Mayo Clinic Proceedings. 2009 ; 84(7) : 632-638. doi: 10.1016/S0025-6196(11)60752-0.
- XUE N, JIA L, LI Q. Potential of natural medicines for treatment of osteoporosis: a narrative review. J Tradit Chin Med, 2023 ; 43(1) : 198-204. doi: 10.19852/j.cnki.jtcm.20221108.003.
- Jia M, Nie Y, Cao DP, Xue YY, Wang JS, Zhao L, Rahman K, Zhang QY, and Qin LP. Potential Antiosteoporotic Agents from Plants: A Comprehensive Review. Evid Based Complement Alternat Med, 2012 ; :2012 : 364604. doi: 10.1155/2012/364604.
- Kim JH, Kim N. Regulation of NFATc1 in Osteoclast Differentiation. J Bone Metab. 2014 ; 21(4) : 233-41. doi: 10.11005/jbm.2014.21.4.233.
- Herbology Editorial Committee of Korean Medicine : Herbology. Younglimsa 2009 ; 607-8.
- Nam HS, Cho MK. The anti-cancer effects of Ampelopsisradix Extract (AE) on A549 cells - The role of Bcl-2 family protein on the AE-induced apoptosis-. Journal of Society of Preventive Korean Medicine. 2012;16(1):71-80. UCI: G704-002177.2012.16.1.001.
- Kim JH, Chun JH, Kim SY, Park YK. The Effects of Ampelopsis Radix on Allergic Inflammation in PMA-stimulated Human Mast Cells. The Korea Journal of Herbology. 2008 ; 23(4) : 91-101.
- Cho YH, Sim GS, Kim JH, Park SM, Lee BC, Pyo HB, Yun YP, Park HD. Effect of Melothria heterophylla Extract on Expression of Matrix Metalloproteinase-1 in Human Skin Fibroblasts. Yakhak Hoeji. 2004 ; 48(6) : 358-363. UCI: G704-000392.2004.48.6.008. G704-000392.2004.48.6.008
- Kim JH, Shin H, Kim M, Kim S, Song K, Jung HS and Sohn Y. Solanum nigrum Line inhibits osteoclast differentiation and suppresses bone mineral density reduction in the ovariectomy-induced osteoporosis model. Molecular medicine reports. 2021 ; 24(2) 607. doi: 10.3892/mmr.2021.12246.
- Ballanti P, Minisola S, Pacitti MT, Scarnecchia L, Rosso R, Mazzuoli GF, Bonucci E. Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry. Osteoporosis international. 1997 ; 7(1) : 39-43. doi: 10.1007/BF01623458.
- Teitelbaum SL. Osteoclasts: what do they do and how do they do it?. The American journal of pathology. 2007 ; 170(2) : 427-435. doi: 10.2353/ajpath.2007.060834.
- Rumpler M, Wurger T, Roschger P, Zwettler E, Sturmlechner I, Altmann P, Fratzl P, Rogers MJ, Klaushofer K. Osteoclasts on Bone and Dentin In Vitro: Mechanism of Trail Formation and Comparison of Resorption Behavior. Calcified tissue international. 2013 ; 93(6) : 526-539. doi: 10.1007/s00223-013-9786-7.
- Ikeda F, Matsubara T, Tsurukai T, Hata K, Nishimura R, Yoneda T. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. Journal of Bone and Mineral Research. 2008 ; 23(6) : 907-914. doi: 10.1359/jbmr.080211.
- Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental cell. 2002 ; 3(6) : 889-901. doi: 10.1016/s1534-5807(02)00369-6.
- Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nature medicine. 2006 ; 12(12) : 1403- 1409. doi: 10.1038/nm1514.
- Cackowski FC, Anderson JL, Patrene KD, Choksi RJ, Shapiro SD, Windle JJ, Blair HC, Roodman GD. Osteoclasts are important for bone angiogenesis. Blood. 2010 ; 115(1) : 140-149. doi: 10.1182/blood2009-08-237628.
- Ishibashi O, Niwa S, Kadoyama K, Inui T. MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life sciences. 2006 ; 79(17) : 1657-1660. doi: 10.1016/j.lfs.2006.05.024.
- Nishi Y, Atley L, Eyre DE, Edelson JG, SupertiFurga A, Yasuda T, Desnick RJ, Gelb BD. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation. Journal of Bone and Mineral Research. 1999 ; 14(11) : 1902-1908. doi: 10.1359/jbmr.1999.14.11.1902.
- Lehenkari P, Hentunen TA, Laitala-Leinonen T, Tuukkanen J, Vaananen HK. Carbonic anhydrase II plays a major role in osteoclast differentiation and bone resorption by effecting the steady state intracellular pH and Ca2+ . Experimental cell research. 1998 ; 242(1) : 128-137. doi: 10.1006/excr.1998.4071.